Dry Powder Inhaler Devices – Medical Devices Pipeline Assessment, 2016


Posted December 7, 2016 by Shirley

“Dry Powder Inhaler Devices – Medical Devices Pipeline Assessment, 2016″ provides an overview of Dry Powder Inhaler Devices currently in pipeline stage.

 
MRRS adds "Dry Powder Inhaler Devices – Medical Devices Pipeline Assessment, 2016" latest studies, published in Nov 2016.

Summary
GlobalData’s Medical Devices sector report, “Dry Powder Inhaler Devices – Medical Devices Pipeline Assessment, 2016″ provides an overview of Dry Powder Inhaler Devices currently in pipeline stage.

Scope
– Extensive coverage of the Dry Powder Inhaler Devices under development
– The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
– The report reviews the major players involved in the development of Dry Powder Inhaler Devices and list all their pipeline projects
– The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
– The report provides key clinical trial data of ongoing trials specific to pipeline products
– Recent developments in the segment / industry

Table of Contents
1 Table of Contents 2
2 Introduction 7
2.1 Dry Powder Inhaler Devices Overview 7
3 Products under Development 8
3.1 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development 8
3.2 Dry Powder Inhaler Devices - Pipeline Products by Territory 9
3.3 Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path 10
3.4 Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date 11
3.5 Dry Powder Inhaler Devices - Ongoing Clinical Trials 12
4 Dry Powder Inhaler Devices - Pipeline Products under Development by Companies 13
4.1 Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development 13
4.2 Dry Powder Inhaler Devices - Pipeline Products by Stage of Development 15
5 Dry Powder Inhaler Devices Companies and Product Overview 16
5.1 Acorda Therapeutics, Inc. Company Overview 16
5.1.1 Acorda Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Adamis Pharmaceuticals Corporation Company Overview 19
5.2.1 Adamis Pharmaceuticals Corporation Pipeline Products & Ongoing Clinical Trials Overview
5.3 Advent Pharmaceuticals Pty Ltd Company Overview 22
5.3.1 Advent Pharmaceuticals Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 Aespira Ltd. Company Overview 23
5.4.1 Aespira Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 AKELA Pharma Inc. (Inactive) Company Overview 24
5.5.1 AKELA Pharma Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 Bayer HealthCare AG Company Overview 26
5.6.1 Bayer HealthCare AG Pipeline Products & Ongoing Clinical Trials Overview 26
5.7 Bespak Europe Ltd. Company Overview 28
5.7.1 Bespak Europe Ltd. Pipeline Products & Ongoing Clinical Trials Overview 28
5.8 GlaxoSmithKline Plc Company Overview 29
5.8.1 GlaxoSmithKline Plc Pipeline Products & Ongoing Clinical Trials Overview 29
5.9 Hovione FarmaCiencia SA Company Overview 31
5.9.1 Hovione FarmaCiencia SA Pipeline Products & Ongoing Clinical Trials Overview 31
5.10 MannKind Corporation Company Overview 33
5.10.1 MannKind Corporation Pipeline Products & Ongoing Clinical Trials Overview 33
5.11 Nanotherapeutics, Inc. Company Overview 35
5.12 Nektar Therapeutics Company Overview 38
5.12.1 Nektar Therapeutics Pipeline Products & Ongoing Clinical Trials Overview 38
5.13 Novartis AG Company Overview 40
5.13.1 Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 40
5.14 OPKO Health, Inc. Company Overview 44
5.14.1 OPKO Health, Inc. Pipeline Products & Ongoing Clinical Trials Overview 44
5.15 Pharmaxis Limited Company Overview 46
5.15.1 Pharmaxis Limited Pipeline Products & Ongoing Clinical Trials Overview 46
5.16 Respira Therapeutics, Inc. Company Overview 48
5.16.1 Respira Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 48...

List of Tables and Figures
Table 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development 8
Table 2: Dry Powder Inhaler Devices - Pipeline Products by Territory 9
Table 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path 10
Table 4: Dry Powder Inhaler Devices - Pipeline Products by Estimated Approval Date 11
Table 5: Dry Powder Inhaler Devices - Ongoing Clinical Trials 12
Table 6: Dry Powder Inhaler Devices Companies - Pipeline Products by Stage of Development 13
Table 7: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development 15
Table 8: Acorda Therapeutics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 16
Table 9: CVT-301 Drug Delivery Device - Product Status 17
Table 10: CVT-301 Drug Delivery Device - Product Description 17
Figure 1: Dry Powder Inhaler Devices - Pipeline Products by Stage of Development 8
Figure 2: Dry Powder Inhaler Devices - Pipeline Products by Territory 9
Figure 3: Dry Powder Inhaler Devices - Pipeline Products by Regulatory Path 10...

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/dry-powder-inhaler-devices-medical-devices-pipeline-assessment-2016

Ask a sample or any futher questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Market Research Report Store
Country United States
Categories Business , Medical , Research
Last Updated December 7, 2016